For manuscript preparation please follow the frame and the simple recommendations and examples reported below
Note: All manuscripts must submitted to the following address Questo indirizzo email è protetto dagli spambots. È necessario abilitare JavaScript per vederlo. written in word format, double spaced, using Times New Roman font, point size 12. The lines must be numbered. For more details see "Instructions to authors"
Title: ............................
Authors (Example)
Silvano Esposito1, Enrico Russo1, Silvana Noviello2
Affiliation (Example)
1Infectious Diseases Unit, University of Salerno, Italy
2Department of Microbiology, San Giovanni di Dio e Ruggi d'Aragona Hospital, Salerno, Italy
Summary (check for word limits)
Text (words limits: review 5000, original article 4000, case report 2000, letter to the editor 1000). References must be numbered consecutively in the order of appearance in the text with Arabic numbers in brackets (example [1,20] or [1-5]) at the end of sentence.
Keywords: .....................
Conflict of Interest: ....................
Funding: ...........................
References (examples)
[1] Cirioni O, Castelletti S, Ucciferri C, et al. Antiretroviral therapy management and rationalization of available resources. Infez Med. 2015;24(4):330-e35. doi: 0000000/000000000000 Last accessed Month day, year.
[2] Abbas M, Uckay I, Lipsky BA. In diabetic foot infection antibiotics are to treat infection, not to heal wounds. Expert Opin Pharmacother: 2015;16(6),821-832. doi: 0000000/000000000000 Last accessed Month day, year.
[3] Reynolds P.E. Inhibitors of bacterial cell wall synthesis, In The Scientific Basis of Antimicrobial Chemotherapy (Greenwood D. and O’Grady F., Eds). Cambridge University Press, Cambridge; 1985: 13-40.
[4] The European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpointtables for interpretation of MICs and zone diameters. Version 9.0, 2019. Available at: http://www.eucast.org. [accessed 15 June 2019].
Table 1 - legend ..................
Table 2 - legend ..................
Figure 1 - legend .................
Figure 2 - legend ..................